Discontinuation report MENACTRA
Report ID | 258386 |
Drug Identification Number | 02279924 |
Brand name | MENACTRA |
Common or Proper name | Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine |
Company Name | SANOFI PASTEUR LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP C MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP Y MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP W 135 MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP A |
Strength(s) | 4.0MCG 4.0MCG 4.0MCG 4.0MCG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1 x 0.5 mL vial |
ATC code | J07AH |
ATC description | BACTERIAL VACCINES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2025-04-01 |
Actual discontinuation date | 2025-04-01 |
Remaining supply date | 2025-08-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Remaining supply date is August 31, 2025 |
Company comments | Menactra is substituted by MenQuadfi (DIN #02507161). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2025-05-28 | English | Compare |
v2 | 2025-05-28 | English | Compare |
v3 | 2025-05-28 | French | Compare |
v4 | 2025-06-05 | English | Compare |
v5 | 2025-06-05 | English | Compare |
v6 | 2025-06-05 | French | Compare |
Showing 1 to 6 of 6